Works by Zakharova, M. N.

Results: 21
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    A Comparative Placebo-Controlled Clinical Trial of the Efficacy and Safety of Interferon β-1a Formulations for S.C. Administration in Patients with Remitting Multiple Sclerosis: First-Year Results.

    Published in:
    Neuroscience & Behavioral Physiology, 2018, v. 48, n. 7, p. 883, doi. 10.1007/s11055-018-0643-z
    By:
    • Boiko, A. N.;
    • Bosenko, L. P.;
    • Vasilovskii, V. V.;
    • Volkova, L. I.;
    • Zakharova, M. N.;
    • Kotov, S. V.;
    • Lekomtseva, E. V.;
    • Negrich, T. I.;
    • Parshina, E. V.;
    • Patrusheva, O. P.;
    • Prokopenko, S. V.;
    • Sazonov, D. V.;
    • Timchenko, P. V.;
    • Trinitatskii, Yu. V.;
    • Khabirov, F. A.;
    • Khavunka, M. Ya.;
    • Chichanovskaya, L. V.;
    • Sherman, M. A.;
    • Lin'kova, Yu. N.;
    • Zinkina-Orikhan, A. V.
    Publication type:
    Article
    14

    A Comparative Placebo-Controlled Clinical Trial of the Efficacy and Safety of Glatiramer Acetate 20 mg in Patients with Remitting Multiple Sclerosis: First-Year Study Results.

    Published in:
    Neuroscience & Behavioral Physiology, 2018, v. 48, n. 3, p. 351, doi. 10.1007/s11055-018-0570-z
    By:
    • Boiko, A. N.;
    • Lashch, N. Yu.;
    • Sharanova, S. N.;
    • Zakharova, M. N.;
    • Trifonova, O. V.;
    • Simaniv, T. O.;
    • Lysogorskaya, E. V.;
    • Gur’yanova, O. E.;
    • Kotov, S. V.;
    • Yakushina, T. I.;
    • Lizhdvoi, V. Yu.;
    • Belova, Yu. A.;
    • Khabirov, F. A.;
    • Babicheva, N. N.;
    • Khaibullin, T. I.;
    • Granatov, E. V.;
    • Aver’yanova, L. A.;
    • Sazonov, D. V.;
    • Odinak, M. M.;
    • Trinitatskii, Yu. V.
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21